thiophenes has been researched along with Renal Insufficiency in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (9.68) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 25 (80.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmanová, I; Sánchez, D | 1 |
| Barrios, V; Escobar, C | 1 |
| Bock, F; Hartung, K; Isermann, B; Meyer, F | 1 |
| Dalmau, FG | 1 |
| Böhm, M; Dichgans, M; Diener, HC; Ell, C; Endres, M; Epple, C; Grond, M; Laufs, U; Nickenig, G; Riess, H; Röther, J; Schellinger, PD; Spannagl, M; Steiner, T; Veltkamp, R | 1 |
| Scheen, AJ | 1 |
| Sabouret, P; Taiel-Sartral, M | 1 |
| Becker, RC; Califf, RM; Fox, KA; Girgis, IG; Halperin, JL; Mahaffey, KW; Moore, KT; Nessel, CC; Patel, MR; Peters, GR | 1 |
| Ariyawansa, J; Haskell, L; Moore, KT; Natarajan, J; Turner, KC; Vaidyanathan, S | 1 |
| Chatterjee, S; Halperin, JL; Herzog, E; Mukherjee, D; Nairooz, R; Sardar, P | 1 |
| Furihata, K; Inagaki, N; Ishii, M; Kondo, K; Kuki, H; Sakai, M; Yoshinari, T | 1 |
| Conway, SE; Mitchell, AP | 1 |
| Kadokura, T; Keirns, J; Krauwinkel, W; Leeflang, S; Nakajo, I; Smulders, R; Taniuchi, Y; Zhang, W | 1 |
| Ishikawa, H; Kashiwagi, A; Kazuta, K; Takahashi, H; Ueyama, E; Utsuno, A; Yoshida, S | 1 |
| Finsterer, J; Stöllberger, C | 1 |
| Gulseth, MP; Michaud, J; Nutescu, EA | 1 |
| Paz Yepes, M; Rodríguez Castilla, J | 1 |
| Gaspari, F; Herz, M; Perico, N; Rabbia, M; Urbanowska, T; Viberti, G; Wieczorek Kirk, D | 1 |
| Becka, M; Bruck, H; Halabi, A; Klause, N; Kubitza, D; Lufft, V; Maatouk, H; Mueck, W; Philipp, T; Wand, DD | 1 |
| Ahrweiler, S; Braun, M; Cawello, W; Sulowicz, W; Szymczakiewicz-Multanowska, A | 1 |
| Becker, RC; Califf, RM; Fox, KA; Halperin, JL; Hankey, GJ; Mahaffey, KW; Nessel, CC; Paolini, JF; Patel, MR; Piccini, JP; Singer, DE; Wojdyla, D | 1 |
| Tripodi, A | 1 |
| Lipták, J | 1 |
| Crowther, MA; Siegal, DM | 1 |
| Goto, S; Hori, M; Iwamoto, K; Izumi, T; Kajikawa, M; Kato, M; Koretsune, Y; Matsumoto, M; Momomura, S; Tajiri, M; Tanahashi, N; Uchiyama, S; Ueda, H | 1 |
| Shiga, T | 1 |
| Akyol, O; Gergerlioglu, S; Iraz, M; Ozyurt, H; Sogut, S; Yildirim, Z; Yilmaz, HR | 1 |
| Gayken, J; Haight, R; Westanmo, AD | 1 |
| Guillet, C | 1 |
| Boike, SC; Chapelsky, MC; Ilson, B; Jorkasky, DK; Martin, DE; Tenero, D; Zariffa, N | 1 |
| Ilson, BE; Jorkasky, DK; Kovacs, SJ; Martin, DE; Tenero, DM | 1 |
14 review(s) available for thiophenes and Renal Insufficiency
| Article | Year |
|---|---|
Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Humans; Ischemic Attack, Transient; Medication Adherence; Morpholines; Renal Insufficiency; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; Thromboembolism; Vitamin K; Warfarin | 2013 |
[From heparin to apixaban: anticoagulants cut both ways?].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Blood Coagulation Tests; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; International Normalized Ratio; Liver Failure; Metabolic Clearance Rate; Morpholines; Perioperative Care; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency; Rivaroxaban; Thiophenes; Thrombocytopenia; Thrombosis; Vitamin K | 2014 |
[The new oral anticoagulants in special populations].
Topics: Administration, Oral; Age Factors; Anticoagulants; Benzimidazoles; Contraindications; Dabigatran; Embolism; Humans; Morpholines; Obesity; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency; Rivaroxaban; Stroke; Thiophenes; Thrombosis | 2012 |
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.
Topics: Administration, Oral; Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Renal Insufficiency; Rivaroxaban; Thiophenes | 2013 |
Evaluating SGLT2 inhibitors for type 2 diabetes: pharmacokinetic and toxicological considerations.
Topics: Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Interactions; Glucosides; Hepatic Insufficiency; Humans; Hypoglycemic Agents; Membrane Transport Modulators; Renal Insufficiency; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2014 |
New antiplatelet agents in the treatment of acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Artery Bypass; Coronary Thrombosis; Diabetes Complications; Hemorrhage; Humans; Multicenter Studies as Topic; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Precision Medicine; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Renal Insufficiency; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome | 2014 |
Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Renal Insufficiency; Rivaroxaban; Stroke; Thiophenes; Thromboembolism | 2014 |
Rivaroxaban for treatment of venous thromboembolism in older adults.
Topics: Aged; Aged, 80 and over; Aging; Factor Xa Inhibitors; Humans; Kidney; Morpholines; Pulmonary Embolism; Recurrence; Renal Insufficiency; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2014 |
Clinical pharmacokinetics and pharmacodynamics of the novel SGLT2 inhibitor ipragliflozin.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Male; Middle Aged; Renal Insufficiency; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2014 |
Rivaroxaban: an oral direct inhibitor of factor Xa.
Topics: Aging; Antithrombin III; Clinical Trials as Topic; Drug Interactions; Fibrinolytic Agents; Hepatic Insufficiency; Humans; Morpholines; Obesity; Prothrombin Time; Renal Insufficiency; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2008 |
The laboratory and the new oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Hemostasis; Humans; Liver Diseases; Morpholines; Pyrazoles; Pyridones; Renal Insufficiency; Rivaroxaban; Thiophenes | 2013 |
Acute management of bleeding in patients on novel oral anticoagulants.
Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Hemorrhage; Hemostatics; Humans; Morpholines; Plasma; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Renal Dialysis; Renal Insufficiency; Risk Factors; Rivaroxaban; Thiophenes | 2013 |
Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Area Under Curve; Depressive Disorder; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Formularies as Topic; Humans; Liver Failure; Randomized Controlled Trials as Topic; Renal Insufficiency; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence | 2005 |
Overview of novel renal properties of tertatolol.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Humans; Hypertension; Kidney; Propanolamines; Renal Circulation; Renal Insufficiency; Thiophenes | 1993 |
10 trial(s) available for thiophenes and Renal Insufficiency
| Article | Year |
|---|---|
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Coagulation; Double-Blind Method; Factor Xa; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Models, Biological; Morpholines; Prothrombin Time; Renal Insufficiency; Rivaroxaban; Thiophenes | 2014 |
An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function.
Topics: Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Erythromycin; Factor Xa; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Partial Thromboplastin Time; Prothrombin Time; Renal Insufficiency; Rivaroxaban; Thiophenes | 2014 |
Pharmacokinetic and pharmacodynamic profiles of canagliflozin in Japanese patients with type 2 diabetes mellitus and moderate renal impairment.
Topics: Adult; Aged; Area Under Curve; Asian People; Canagliflozin; Cross-Over Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glucosides; Humans; Hypoglycemic Agents; Japan; Male; Middle Aged; Renal Insufficiency; Thiophenes | 2014 |
A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the long-term ASP1941 safety evaluation in patients with type 2 dia
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Renal Insufficiency; Thiophenes; Time Factors; Treatment Outcome; Weight Loss | 2015 |
Effects of high dose aleglitazar on renal function in patients with type 2 diabetes.
Topics: Adolescent; Adult; Aged; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Middle Aged; Oxazoles; Prognosis; Renal Insufficiency; Retrospective Studies; Thiophenes; Young Adult | 2011 |
Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function.
Topics: Adult; Aged; Area Under Curve; Case-Control Studies; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Renal Insufficiency; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2012 |
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Embolism; Female; Hemorrhage; Humans; Male; Morpholines; Renal Insufficiency; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin | 2011 |
Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Asian People; Atrial Fibrillation; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Japan; Kidney; Male; Middle Aged; Morpholines; Renal Insufficiency; Reproducibility of Results; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin | 2013 |
Overview of novel renal properties of tertatolol.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Humans; Hypertension; Kidney; Propanolamines; Renal Circulation; Renal Insufficiency; Thiophenes | 1993 |
Pharmacokinetics and protein binding of eprosartan in hemodialysis-dependent patients with end-stage renal disease.
Topics: Acrylates; Adult; Antihypertensive Agents; Female; Humans; Imidazoles; Male; Middle Aged; Protein Binding; Renal Dialysis; Renal Insufficiency; Thiophenes | 1999 |
8 other study(ies) available for thiophenes and Renal Insufficiency
| Article | Year |
|---|---|
Metabolic acidosis and anaemia associated with dorzolamide in a patient with impaired renal function.
Topics: Acidosis; Administration, Ophthalmic; Anemia; Carbonic Anhydrase Inhibitors; Fatigue; Glaucoma; Humans; Male; Middle Aged; Renal Insufficiency; Sulfonamides; Thiophenes | 2018 |
Rivaroxaban 10mg/d in severe renal failure does not prevent ischemic events in premorbid neurologic disease.
Topics: Aged, 80 and over; Atrial Fibrillation; Factor Xa Inhibitors; Female; Humans; Morpholines; Recurrence; Renal Insufficiency; Rivaroxaban; Stroke; Thiophenes | 2015 |
[Rash and renal failure secondary to strontium ranelate].
Topics: Aged; Bone Density Conservation Agents; Drug Eruptions; Female; Humans; Organometallic Compounds; Renal Insufficiency; Thiophenes | 2010 |
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor.
Topics: Administration, Oral; Adult; Aged; Area Under Curve; Cohort Studies; Creatinine; Factor Xa Inhibitors; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Morpholines; Renal Insufficiency; Rivaroxaban; Thiophenes | 2010 |
[Rivaroxaban versus warfarin: results of the ROCKET study].
Topics: Anticoagulants; Atrial Fibrillation; Brain Ischemia; Double-Blind Method; Humans; Morpholines; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Renal Insufficiency; Rivaroxaban; Secondary Prevention; Severity of Illness Index; Stroke; Thiophenes; Treatment Outcome; Warfarin | 2012 |
Reconsideration of anticoagulant therapy in Japanese patients with atrial fibrillation and moderate renal impairment.
Topics: Anticoagulants; Asian People; Atrial Fibrillation; Female; Humans; Male; Morpholines; Renal Insufficiency; Rivaroxaban; Stroke; Thiophenes | 2013 |
The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats.
Topics: Animals; Cisplatin; Glucosephosphate Dehydrogenase; Kidney; Malate Dehydrogenase; Rats; Renal Insufficiency; Thioglycolates; Thiophenes | 2004 |
Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment.
Topics: Acrylates; Adult; Aged; Antihypertensive Agents; Area Under Curve; Humans; Imidazoles; Metabolic Clearance Rate; Middle Aged; Renal Insufficiency; Thiophenes | 1998 |